Genisphere LLC is the provider of the 3DNA® platform for targeted drug delivery. 3DNA® is a nanoscale, multivalent scaffold made from proprietary, synthetic DNA formed in a flexible, branched structure. 3DNA® nanocarriers are engineered and crosslinked to form a stable architecture while maintaining the biocompatibility of the nucleic acid building blocks, and demonstrate efficacy and safety with a variety of drug cargos across multiple indications. Genisphere's technology is IP-protected and fully customizable to deliver small molecules, biologics, and nucleic acids with precise specificity enabled by multivalent targeting via antibodies, peptides and other molecular entities. Genisphere leverages a collaborative model to advance its 3DNA® drug delivery platform, and seeks additional partnerships with biotechnology and pharmaceutical companies to improve efficacy and reduce toxicity. Genisphere is also advancing its own lead programs based on 3DNA® nanotechnology. Our mission is to expand our collaborative partnerships and utilize our longstanding nanotechnology expertise to enhance the human condition through new 3DNA-based therapeutics. For us, this mission is much more than words on a page. We live this mission every day as we employ the unique characteristics of our flexible platform to support our continuing partnerships and to advance our own lead programs based on 3DNA® nanotechnology.
Looking for a particular Genisphere employee's phone or email?
The Genisphere annual revenue was $4 million in 2026.
Jim Kadushin is the Director, Operations of Genisphere.
5 people are employed at Genisphere.
Genisphere is based in Hatfield, Pennsylvania.
The NAICS codes for Genisphere are [541, 54, 5417, 54171, 541714].
The SIC codes for Genisphere are [87, 873].